Descrizione

The global flow cytometry market is poised to grow by US$ 3,380.4 million during 2022-2028, procedendo a un CAGR di 8.3% durante il periodo di previsione, secondo la società di dati e analisi StrategyHelix.

Il rapporto fornisce dati aggiornati sulle dimensioni del mercato per il periodo 2018-2021 e previsione a 2028 covering key market aspects like sales value for flow cytometry. The global flow cytometry market is segmented on the basis of product, tecnologia, application, end user, e regione. Per prodotto, the global flow cytometry market has been segmented into kits and reagents, instruments, software and services, others. The kits and reagents segment was the largest contributor to the global flow cytometry market in 2021. Based upon technology, the global flow cytometry market is categorized into cell-based flow cytometry, bead-based flow cytometry. According to the research, the cell-based flow cytometry segment had the largest share in the global flow cytometry market. On the basis of application, the global flow cytometry market has been segmented into cancer, drug discovery, stem cell therapy, organ transplantation, hematologic malignancy, others. The cancer segment held the largest revenue share in 2021. By end user, the global flow cytometry market has been segmented into hospitals and clinics, research institutes, pharmaceutical companies, others. Globally, the hospitals and clinics segment made up the largest share of the flow cytometry market. Geograficamente, the global flow cytometry market is segmented into North America, Europa, Asia-Pacific, MEA (Medio Oriente e Africa), America Latina.

The global flow cytometry market is highly competitive. The report also includes the profiles of leading companies such as Agilent Technologies Inc., Becton Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, Enzo Biochem Inc., Luminex Corporation, Miltenyi Biotec B.V. & CO. KG, Sysmex Corporation, Thermo Fisher Scientific Inc. Competitive landscape gives a description of the competitive nature of the global flow cytometry market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

Il rapporto è una risorsa inestimabile per le aziende e le organizzazioni attive in questo settore. It provides a cohesive picture of the flow cytometry market to help drive informed decision making for industry executives, decisori politici, accademico, e analisti.

Ambito del rapporto

Prodotto: kits and reagents, instruments, software and services, others
Tecnologia: cell-based flow cytometry, bead-based flow cytometry
Application: cancer, drug discovery, stem cell therapy, organ transplantation, hematologic malignancy, others
End user: hospitals and clinics, research institutes, pharmaceutical companies, others
Regione: Nord America, Europa, Asia-Pacific, MEA (Medio Oriente e Africa), America Latina
Anni considerati: la presente relazione copre il periodo 2018 A 2028
Company mentioned: Agilent Technologies Inc., Becton Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, Enzo Biochem Inc., Luminex Corporation, Miltenyi Biotec B.V. & CO. KG, Sysmex Corporation, Thermo Fisher Scientific Inc.

Principali vantaggi per gli stakeholder

– Get a comprehensive picture of the global flow cytometry market
– Individuare i settori in crescita e le tendenze per gli investimenti

Sommario

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Metodologia di ricerca
Part 2. Flow cytometry market overview
Part 3. Market breakdown by product
– Kits and reagents
– Instruments
– Software and services
– Altri
Part 4. Market breakdown by technology
– Cell-based flow cytometry
– Bead-based flow cytometry
Part 5. Market breakdown by application
– Cancer
– Drug discovery
– Stem cell therapy
– Organ transplantation
– Hematologic malignancy
– Altri
Part 6. Market breakdown by end user
– Hospitals and clinics
– Research institutes
– Pharmaceutical companies
– Altri
Part 7. Market breakdown by region
– Nord America
– Europa
– Asia-Pacific
– MEA (Medio Oriente e Africa)
– America Latina
Part 8. Key companies
– Agilent Technologies, Inc.
– Becton, Dickinson and Company
– BioMerieux SA
– Bio-Rad Laboratories Inc.
– Danaher Corporation
– Enzo Biochem Inc.
– Luminex Corporation
– Miltenyi Biotec B.V. & CO. KG
– Sysmex Corporation
– Thermo Fisher Scientific Inc.
Informazioni su StrategyHelix
Disclaimer